ABVC BioPharma, Inc. last reported quarterly results on Mar 3, 2026, for Q4 FY2025 (the quarter ended Dec 31, 2025): revenue of $499,950 and diluted EPS of -$0.11. It usually reports 15–62 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 15–62 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Mar 3, 2026
62 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
-0
|
-3
-278.2%
|
-0.11
-114.2%
|
|
Nov 3, 2025
34 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
1
|
-2
-417.4%
|
-0.09
-200.0%
|
|
Aug 14, 2025
45 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
—
|
-2
|
-0.13
-62.5%
|
|
Apr 15, 2025
15 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
—
|
-1
+70.3%
|
-0.06
+79.3%
|
|
Nov 14, 2024
45 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
0
+2350.7%
|
-0
+88.1%
|
-0.03
+96.3%
|
|
Aug 15, 2024
46 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
Mar 14, 2024
74 days after quarter end
|
—
ended Dec 31, 2023
|
—
|
—
|
—
|
|
Nov 15, 2023
46 days after quarter end
|
—
ended Sep 30, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABVC (Nasdaq), ECOC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fremont, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1173313
- Former names
- American BriVision (Holding) Corp (until Apr 8, 2021); METU BRANDS, INC. (until Jan 8, 2016); Ecology Coatings, Inc. (until Sep 2, 2015); ECOLOGY COATINGS, INC. (until Sep 2, 2015); OCIS CORP (until Jun 13, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.